EP2892564 - HYALURONIC ACID-BASED DRUG DELIVERY SYSTEMS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.10.2020 Database last updated on 19.07.2024 | |
Former | Examination is in progress Status updated on 08.11.2019 | Most recent event Tooltip | 02.10.2020 | Application deemed to be withdrawn | published on 04.11.2020 [2020/45] | Applicant(s) | For all designated states Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | [2015/29] | Inventor(s) | 01 /
VENKATRAMAN, Subramanian c/o Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | 02 /
HOWDEN, Tina Tzee Ling c/o Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | 03 /
WIDJAJA, Leonardus, Kresna c/oNanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | [2015/29] | Representative(s) | Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE | [N/P] |
Former [2015/29] | Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE | Application number, filing date | 13834865.1 | 06.09.2013 | WO2013SG00389 | Priority number, date | US201261697296P | 06.09.2012 Original published format: US 201261697296 P | [2015/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014039012 | Date: | 13.03.2014 | Language: | EN | [2014/11] | Type: | A1 Application with search report | No.: | EP2892564 | Date: | 15.07.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.03.2014 takes the place of the publication of the European patent application. | [2015/29] | Search report(s) | International search report - published on: | AU | 13.03.2014 | (Supplementary) European search report - dispatched on: | EP | 30.03.2016 | Classification | IPC: | A61K47/36, A61K31/728, A61K9/127, A61K31/765, A61K31/722, A61K31/5575, A61K31/505, A61K39/395, A61K31/7105, A61K31/711, A61P27/06, A61K9/16, A61K9/51 | [2016/17] | CPC: |
A61K47/36 (EP,US);
A61K31/216 (EP,US);
A61K31/513 (EP,US);
A61K31/5575 (EP,US);
A61K31/7105 (EP,US);
A61K31/728 (EP,US);
A61K9/0014 (EP,US);
A61K9/0019 (EP,US);
A61K9/06 (EP,US);
A61K9/127 (EP,US);
A61K9/1647 (EP,US);
A61K9/5161 (EP,US);
A61P27/06 (EP);
Y10S977/773 (EP,US);
Y10S977/906 (EP,US);
Y10S977/907 (EP,US)
(-)
|
Former IPC [2015/29] | A61K47/36, A61K31/728, A61K9/127, A61K31/765, A61K31/722, A61K31/5575, A61K31/505, A61K39/395, A61K31/7105, A61K31/711, A61P27/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/29] | Title | German: | ARZNEISTOFFABGABESYSTEME AUF BASIS VON HYALURONSÄURE | [2015/29] | English: | HYALURONIC ACID-BASED DRUG DELIVERY SYSTEMS | [2015/29] | French: | SYSTÈMES D'ADMINISTRATION DE MÉDICAMENT À BASE D'ACIDE HYALURONIQUE | [2015/29] | Entry into regional phase | 01.04.2015 | National basic fee paid | 01.04.2015 | Search fee paid | 01.04.2015 | Designation fee(s) paid | 01.04.2015 | Examination fee paid | Examination procedure | 01.04.2015 | Examination requested [2015/29] | 24.10.2016 | Amendment by applicant (claims and/or description) | 13.11.2019 | Despatch of a communication from the examining division (Time limit: M04) | 03.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/45] | 25.06.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/45] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.11.2019 | Fees paid | Renewal fee | 25.09.2015 | Renewal fee patent year 03 | 22.09.2016 | Renewal fee patent year 04 | 26.09.2017 | Renewal fee patent year 05 | 25.09.2018 | Renewal fee patent year 06 | 24.09.2019 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2010140869 (ILJIN COPPER FOIL CO LTD [KR], et al) [X] 1-9,14,15 * paragraph [0027] - paragraph [0033] * * paragraph [0041] * * example - *; | [X]US2003157161 (HUNTER WILLIAM L [CA], et al) [X] 1-9,14,15 * paragraph [0058] * * paragraph [0064] - paragraph [0065] * * examples 4-6,14 *; | [X]US2001005501 (MARRIOTT CHRISTOPHER [GB], et al) [X] 1-9,14,15 * paragraph [0041] - paragraph [0042] * * paragraph [0055] - paragraph [0056] * * paragraph [0061] - paragraph [0068] * * paragraph [0107] - paragraph [0109] * | International search | [X]US2010285113 (SHOICHET MOLLY S [CA], et al); | [X]US2009226531 (LYONS ROBERT T [US], et al); | [X]WO02087563 (ANGIOTECH PHARM INC [CA], et al) | [X] - LEACH, J.B. ET AL., "Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds", BIOMATERIALS, (2005), vol. 26, pages 125 - 135, XP027768322 | [X] - BAJAJ, G. ET AL., "Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors", JOURNAL OF CONTROLLED RELEASE, (20120328), vol. 158, no. 3, pages 386 - 392, XP055234999 DOI: http://dx.doi.org/10.1016/j.jconrel.2011.12.001 | [X] - BAE, S.E. ET AL., "Effect of temporally controlled release of dexamethasone on in vivo chondrogenic differentiation of mesenchymal stromal cells", JOURNAL OF CONTROLLED RELEASE, (2010), vol. 143, pages 23 - 30, XP026964318 | [X] - LEE, M. ET AL., "Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers", BIOMATERIALS, (2009), vol. 30, no. 30, pages 6094 - 6101, XP026524676 DOI: http://dx.doi.org/10.1016/j.biomaterials.2009.07.046 |